138 related articles for article (PubMed ID: 3020851)
1. The effects of conjugated equine oestrogens with and without a cyclical progestogen on lipoproteins, and HDL subfractions in postmenopausal women.
Farish E; Fletcher CD; Hart DM; Teo HT; Alazzawi F; Howie C
Acta Endocrinol (Copenh); 1986 Sep; 113(1):123-7. PubMed ID: 3020851
[TBL] [Abstract][Full Text] [Related]
2. Short-term changes in lipoproteins and apoproteins during cyclical oestrogen-progestogen replacement therapy.
Fletcher CD; Farish E; Dagen MM; Hart DM
Maturitas; 1991 Dec; 14(1):33-42. PubMed ID: 1665197
[TBL] [Abstract][Full Text] [Related]
3. The effect of medrogestone on plasma lipids and lipoproteins in postmenopausal women using conjugated estrogens: an open randomized comparative study.
Gevers Leuven JA; van der Mooren MJ; Buytenhek R
Fertil Steril; 1995 Sep; 64(3):525-31. PubMed ID: 7641905
[TBL] [Abstract][Full Text] [Related]
4. The effect of various regimens of hormone therapy on serum cholesterol and triglyceride concentrations in postmenopausal women.
Paterson ME; Sturdee DW; Moore B; Whitehead TP
Br J Obstet Gynaecol; 1980 Jul; 87(7):552-60. PubMed ID: 6252948
[TBL] [Abstract][Full Text] [Related]
5. A comparison of the effects of lipoproteins of two progestogens used during cyclical hormone replacement therapy.
Fletcher CD; Farish E; Dagen MM; Hart DM
Maturitas; 1987 Nov; 9(3):253-8. PubMed ID: 3431476
[TBL] [Abstract][Full Text] [Related]
6. Effects of conjugated equine estrogen with and without three different progestogens on lipoproteins, high-density lipoprotein subfractions, and apolipoprotein A-I.
Miller VT; Muesing RA; LaRosa JC; Stoy DB; Phillips EA; Stillman RJ
Obstet Gynecol; 1991 Feb; 77(2):235-40. PubMed ID: 1846437
[TBL] [Abstract][Full Text] [Related]
7. Effect of hormone replacement therapy on lipoprotein(a) and lipid levels in postmenopausal women. Influence of various progestogens and duration of therapy.
Kim CJ; Min YK; Ryu WS; Kwak JW; Ryoo UH
Arch Intern Med; 1996 Aug 12-26; 156(15):1693-700. PubMed ID: 8694668
[TBL] [Abstract][Full Text] [Related]
8. The effects of conjugated equine estrogens plus cyclical dydrogesterone on serum lipoproteins and apoproteins in postmenopausal women.
Fletcher CD; Farish E; Dagen MM; Alazzawi F; McQueen D; Hart DM
Acta Endocrinol (Copenh); 1988 Mar; 117(3):339-42. PubMed ID: 2837887
[TBL] [Abstract][Full Text] [Related]
9. Effects of adding C-19 versus C-21 progestin to conjugated estrogen in moderately hypercholesterolemic postmenopausal women.
Wolfe BM; Koval JJ; Nisker JA
Am J Obstet Gynecol; 1998 Apr; 178(4):787-92. PubMed ID: 9579445
[TBL] [Abstract][Full Text] [Related]
10. Effects of tibolone on serum lipoprotein and apolipoprotein levels compared with a cyclical estrogen/progestogen regimen.
Farish E; Barnes JF; Fletcher CD; Ekevall K; Calder A; Hart DM
Menopause; 1999; 6(2):98-104. PubMed ID: 10374215
[TBL] [Abstract][Full Text] [Related]
11. A two-year clinical study of the effects of two triphasic oral contraceptives on plasma lipids.
Kakis G; Powell M; Marshall A; Woutersz TB; Steiner G
Int J Fertil Menopausal Stud; 1994; 39(5):283-91. PubMed ID: 7820162
[TBL] [Abstract][Full Text] [Related]
12. A long-term study of the effects of norethisterone on lipoprotein metabolism in menopausal women.
Farish E; Fletcher CD; Hart DM; Kitchener H; Sharpe GL
Clin Chim Acta; 1983 Aug; 132(2):193-8. PubMed ID: 6577991
[TBL] [Abstract][Full Text] [Related]
13. A comparison of the effects of two continuous HRT regimens on cardiovascular risk factors.
Barnes JF; Farish E; Rankin M; Hart DM
Atherosclerosis; 2002 Jan; 160(1):185-93. PubMed ID: 11755937
[TBL] [Abstract][Full Text] [Related]
14. Impact of hormone replacement therapy on postprandial lipoproteins and lipoprotein(a) in normolipidemic postmenopausal women.
Julius U; Fritsch H; Fritsch W; Rehak E; Fücker K; Leonhardt W; Hanefeld M
Clin Investig; 1994 Jul; 72(7):502-7. PubMed ID: 7981577
[TBL] [Abstract][Full Text] [Related]
15. Comparison of the effects of conjugated estrogen treatment on blood lipid and lipoprotein levels when initiated in the first or fifth postmenopausal year.
Aygen EM; Karaküçük EI; Başbuğ M
Gynecol Endocrinol; 1999 Apr; 13(2):118-22. PubMed ID: 10399057
[TBL] [Abstract][Full Text] [Related]
16. Effect of conjugated estrogens with and without medrogestone: a prospective study.
van der Mooren MJ; Leuven JA; Rolland R
Maturitas; 1994 May; 19(1):33-42. PubMed ID: 7935030
[TBL] [Abstract][Full Text] [Related]
17. Effect on lipoproteins of Trisequens, a combined hormone preparation.
Fletcher CD; Farish E; Hart DM; Leggate J; Clark DM; Kitchener H; Sharpe GL
Maturitas; 1984 Nov; 6(3):279-83. PubMed ID: 6595494
[TBL] [Abstract][Full Text] [Related]
18. Serum lipoprotein effects of conjugated estrogen and a sequential conjugated estrogen-medrogestone regimen in hysterectomized postmenopausal women.
Sonnendecker EW; Polakow ES; Benadé AJ; Simchowitz E
Am J Obstet Gynecol; 1989 May; 160(5 Pt 1):1128-34. PubMed ID: 2543223
[TBL] [Abstract][Full Text] [Related]
19. Effects of estrogen dose and smoking on lipid and lipoprotein levels in postmenopausal women.
Krauss RM; Perlman JA; Ray R; Petitti D
Am J Obstet Gynecol; 1988 Jun; 158(6 Pt 2):1606-11. PubMed ID: 2837088
[TBL] [Abstract][Full Text] [Related]
20. Effects of postmenopausal hormone replacement therapy on lipoproteins including lipoprotein(a) and LDL subfractions.
Farish E; Spowart K; Barnes JF; Fletcher CD; Calder A; Brown A; Hart DM
Atherosclerosis; 1996 Sep; 126(1):77-84. PubMed ID: 8879436
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
